Angelica Dominguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Angelica Dominguez has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- José Luis Tapia Illanes
Pontificia Universidad Católica de Chile
4 shared publications - Alberto Toso
Pontificia Universidad Católica de Chile
2 shared publications - Catalina Vaz Ferreira
Department of Neonatology, Centro Hospitalario Pereira Rossell, Universidad de la República, Montevideo, Uruguay
2 shared publications - Cecilia Herbozo
School of Medicine, Department of Pediatrics, Universidad Peruana Cayetano Heredia, Lima, Peru
2 shared publications - Daniela Masoli
Department of Neonatology, Pontificia Universidad Católica de Chile, Division of Pediatrics, School of Medicine, Santiago, Chile
2 shared publications Alexis M. Kalergis
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by Sociedad Chilena de Pediatria in Andes Pediatrica
- Vol. 97 (3)
Restricción del crecimiento extrauterino en prematuros de muy bajo peso al nacer en la red neonatal NEOCOSUR
El crecimiento postnatal del prematuro es parte fundamental de la atención médica, ya que determina mejor crecimiento cerebral y con esto mejor evolución neurocognitiva. Dada la morbilidad postnatal, y las diferentes prácticas nutricionales, no es posible mantener el nivel de crecimiento intrauterino normal. El deterioro nutricional postnatal se ha descrito como restricción del crecimiento extrauterino (RCEU) Objetivo: Describir la prevalencia de RCEU en prematuros de muy bajo peso de nacimiento (MBPN) de una red neonatal multicéntrica (NEOCOSUR) e identificar los factores asociados a su ocurrencia. Pacientes y Método: Estudio retrospectivo de datos registrados entre 2006- 2016. RCEU fue definido como peso menor al percentil 10 de curvas de Intergrowth-21al alta. Se analizan las variables asociadas a RCEU. Un modelo de regresión mixto general fue utilizado para evaluar factores independientes asociados con RCEU. Resultados: 8 690 prematuros MBPN fueron incluidos, con edad gestacional de 29 semanas (RIC 28-31) y peso al nacer de 1,177 (RIC 984-1344g) de 27 centros neonatales. La prevalencia de RCEU fue de 49,0% (rango 22,4-89,4% según centro). Las variables independientemente asociadas con RCEU fueron: mayor edad gestacional, pequeño para edad gestacional, displasia broncopulmonar, sepsis tardía, retardo de inicio y de lograr 100 ml/kg/ día de aporte enteral, período de nacimiento y uso postnatal de corticoides. Conclusión: Se identifica una alta y muy variable prevalencia de RCEU, algunos de los factores independientes identificados ofrecen una oportunidad de intervención para la mejoría de evolución nutricional.
- 17 April 2026
- Published by Sociedad Chilena de Pediatria in Andes Pediatrica
- Vol. 97 (3)
Open AccessRestricción del crecimiento extrauterino en prematuros de muy bajo peso al nacer en la red neonatal NEOCOSUR
El crecimiento postnatal del prematuro es parte fundamental de la atención médica, ya que determina mejor crecimiento cerebral y con esto mejor evolución neurocognitiva. Dada la morbilidad postnatal, y las diferentes prácticas nutricionales, no es posible mantener el nivel de crecimiento intrauterino normal. El deterioro nutricional postnatal se ha descrito como restricción del crecimiento extrauterino (RCEU) Objetivo: Describir la prevalencia de RCEU en prematuros de muy bajo peso de nacimiento (MBPN) de una red neonatal multicéntrica (NEOCOSUR) e identificar los factores asociados a su ocurrencia. Pacientes y Método: Estudio retrospectivo de datos registrados entre 2006- 2016. RCEU fue definido como peso menor al percentil 10 de curvas de Intergrowth-21al alta. Se analizan las variables asociadas a RCEU. Un modelo de regresión mixto general fue utilizado para evaluar factores independientes asociados con RCEU. Resultados: 8 690 prematuros MBPN fueron incluidos, con edad gestacional de 29 semanas (RIC 28-31) y peso al nacer de 1,177 (RIC 984-1344g) de 27 centros neonatales. La prevalencia de RCEU fue de 49,0% (rango 22,4-89,4% según centro). Las variables independientemente asociadas con RCEU fueron: mayor edad gestacional, pequeño para edad gestacional, displasia broncopulmonar, sepsis tardía, retardo de inicio y de lograr 100 ml/kg/ día de aporte enteral, período de nacimiento y uso postnatal de corticoides. Conclusión: Se identifica una alta y muy variable prevalencia de RCEU, algunos de los factores independientes identificados ofrecen una oportunidad de intervención para la mejoría de evolución nutricional.
- 13 March 2026
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (8) , 1-6
Association between risk-adjusted mortality and severe morbidity in very low birth weight infants: a multicenter study from the NEOCOSUR network
Background Very low birth weight infants (VLBWI) are at high risk of mortality and severe morbidities. While many neonatal networks monitor risk-adjusted outcomes separately, the relationship between mortality and major morbidities across centers remains unclear. Objective To evaluate the association between risk-adjusted in-hospital mortality and six major morbidities in VLBWI across 20 South American NICUs participating in the NEOCOSUR Network between 2011 and 2023. Methods Retrospective cohort study including 14,100 VLBWI (500–1500 g) from 20 NICUs in Argentina, Chile, Paraguay, Peru, and Uruguay. Observed-to-expected (O/E) ratios for mortality and for each morbidity—late-onset sepsis, bronchopulmonary dysplasia at 36 weeks (BPD), severe intraventricular hemorrhage (IVH grade III–IV), retinopathy of prematurity (ROP ≥ stage III), necrotizing enterocolitis (NEC ≥ stage II), and periventricular leukomalacia (PVL)—were calculated using logistic regression models adjusted for perinatal risk factors. Center-level associations were evaluated using Poisson regression models. Results O/E mortality varied widely across centers (range from 0.62 to 1.48), with 7 centers showing significantly lower-than-expected mortality and 4 with higher-than-expected values. Significant positive associations were found between mortality O/E and O/E of late-onset sepsis (χ² = 53.6, p < 0.01), severe IVH (χ² = 18.0, p < 0.01), ROP (χ² = 38.0, p < 0.01), and PVL (χ² = 23.4, p < 0.01). An inverse association was observed between mortality and BPD (χ² = 36.2, p < 0.01). No significant association was found for NEC. Conclusions Centers with higher-than-expected mortality also showed excess rates of several severe morbidities, suggesting that shared care practices may be associated with multiple outcomes. The inverse association with BPD may reflect a survival bias. These findings support the integration of multiple adjusted outcomes in quality benchmarking across NICUs.
- 13 March 2026
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (8) , 1-6
Association between risk-adjusted mortality and severe morbidity in very low birth weight infants: a multicenter study from the NEOCOSUR network
Background Very low birth weight infants (VLBWI) are at high risk of mortality and severe morbidities. While many neonatal networks monitor risk-adjusted outcomes separately, the relationship between mortality and major morbidities across centers remains unclear. Objective To evaluate the association between risk-adjusted in-hospital mortality and six major morbidities in VLBWI across 20 South American NICUs participating in the NEOCOSUR Network between 2011 and 2023. Methods Retrospective cohort study including 14,100 VLBWI (500–1500 g) from 20 NICUs in Argentina, Chile, Paraguay, Peru, and Uruguay. Observed-to-expected (O/E) ratios for mortality and for each morbidity—late-onset sepsis, bronchopulmonary dysplasia at 36 weeks (BPD), severe intraventricular hemorrhage (IVH grade III–IV), retinopathy of prematurity (ROP ≥ stage III), necrotizing enterocolitis (NEC ≥ stage II), and periventricular leukomalacia (PVL)—were calculated using logistic regression models adjusted for perinatal risk factors. Center-level associations were evaluated using Poisson regression models. Results O/E mortality varied widely across centers (range from 0.62 to 1.48), with 7 centers showing significantly lower-than-expected mortality and 4 with higher-than-expected values. Significant positive associations were found between mortality O/E and O/E of late-onset sepsis (χ² = 53.6, p < 0.01), severe IVH (χ² = 18.0, p < 0.01), ROP (χ² = 38.0, p < 0.01), and PVL (χ² = 23.4, p < 0.01). An inverse association was observed between mortality and BPD (χ² = 36.2, p < 0.01). No significant association was found for NEC. Conclusions Centers with higher-than-expected mortality also showed excess rates of several severe morbidities, suggesting that shared care practices may be associated with multiple outcomes. The inverse association with BPD may reflect a survival bias. These findings support the integration of multiple adjusted outcomes in quality benchmarking across NICUs.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Pediatrics
- Vol. 2026 (1)
Mechanical Ventilation and Survival Without Major Morbidity in Very‐Low‐Birth‐Weight Infants: A Multicenter Study
Background: Mechanical ventilation (MV) is a frequent lifesaving therapy in very low birthweight (VLBW) infants, although it poses risks and may present complications. Objective: To evaluate the association between the use and duration of MV and survival without major morbidity (SWMM) in VLBW infants according to gestational age (GA). Methods: Multicenter retrospective study of prospectively collected data of premature infants weighing 500–1500 g and 24–30 weeks of GA, born between 2010 and 2019 at NEOCOSUR Neonatal Network centers. Baseline characteristics and neonatal outcomes were compared between ventilated and nonventilated VLBW infants. Stratification for each week of GA was performed. Adjusted odds ratios and 95% confidence intervals (CIs) were calculated for main outcomes by logistic regression, adjusted for birthweight, GA, sex, mode of delivery, respiratory distress syndrome (RDS), antenatal corticosteroids, small for gestational age (SGA), and Apgar scores. Infants with congenital anomalies and those who died before discharge were excluded. Results: A total of 7040 infants were included in the analysis. Among these, 4993 (70.9%) were ventilated and 2047 (29.1%) were not. Nonventilated infants were larger, healthier at birth, and presented fewer major adverse outcomes ( p < 0.001). SWMM in ventilated patients was 35.9%, compared with 73.4% in nonventilated infants (OR = 0.35; 95% CI: [0.31–0.40]). SWMM of ventilated infants remained lower at all GA intervals after risk adjustment. MV duration was also associated with a decrease in SWMM; each additional day of MV was associated with 7.9% lower odds of SWMM (OR = 0.921; 95% CI: [0.913–0.930]). Conclusions: The use and duration of MV were associated with a significant decrease in SWMM in this population of VLBW infants, despite risk adjustment.
- 1 January 2026
- Published by Wiley in International Journal of Pediatrics
- Vol. 2026 (1)
Open AccessMechanical Ventilation and Survival Without Major Morbidity in Very‐Low‐Birth‐Weight Infants: A Multicenter Study
Background: Mechanical ventilation (MV) is a frequent lifesaving therapy in very low birthweight (VLBW) infants, although it poses risks and may present complications. Objective: To evaluate the association between the use and duration of MV and survival without major morbidity (SWMM) in VLBW infants according to gestational age (GA). Methods: Multicenter retrospective study of prospectively collected data of premature infants weighing 500–1500 g and 24–30 weeks of GA, born between 2010 and 2019 at NEOCOSUR Neonatal Network centers. Baseline characteristics and neonatal outcomes were compared between ventilated and nonventilated VLBW infants. Stratification for each week of GA was performed. Adjusted odds ratios and 95% confidence intervals (CIs) were calculated for main outcomes by logistic regression, adjusted for birthweight, GA, sex, mode of delivery, respiratory distress syndrome (RDS), antenatal corticosteroids, small for gestational age (SGA), and Apgar scores. Infants with congenital anomalies and those who died before discharge were excluded. Results: A total of 7040 infants were included in the analysis. Among these, 4993 (70.9%) were ventilated and 2047 (29.1%) were not. Nonventilated infants were larger, healthier at birth, and presented fewer major adverse outcomes ( p < 0.001). SWMM in ventilated patients was 35.9%, compared with 73.4% in nonventilated infants (OR = 0.35; 95% CI: [0.31–0.40]). SWMM of ventilated infants remained lower at all GA intervals after risk adjustment. MV duration was also associated with a decrease in SWMM; each additional day of MV was associated with 7.9% lower odds of SWMM (OR = 0.921; 95% CI: [0.913–0.930]). Conclusions: The use and duration of MV were associated with a significant decrease in SWMM in this population of VLBW infants, despite risk adjustment.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Impact of Transport Media on IL‐33 Levels in Samples From Patients With Viral Respiratory Infections
Interleukin‐33 (IL‐33) is an IL‐1 family cytokine that activates various immune cells and induces both systemic and localized Th2 responses during infection. An association between IL‐33 and its suppresion of tumorigenicity 2 (ST2) receptor with inflammation during respiratory tract infection has been previously reported. Furthermore, some data suggest that during respiratory infections, IL‐33 may serve as an indicator of disease severity, as high levels of this cytokine have been found in nasopharyngeal swab (NPS) samples of infants with lower respiratory tract disease caused by respiratory syncytial virus (RSV). As viral diagnosis is mostly compartmentalized in NPS, in this report, we aimed at detecting IL‐33 in NPS from patients with respiratory tract infections that were collected in two different transport media (universal transport medium [UTM], and phosphate‐buffered saline [PBS]). IL‐33 levels were evaluated in 230 NPS samples, 121 obtained in PBS, and 109 in UTM. The samples were tested for RSV, metapneumovirus, adenovirus (ADV), influenza, and parainfluenza. In this cohort, higher levels of IL‐33 were detected in virus‐positive samples collected in PBS compared to virus‐negative samples collected in the same transport medium. In addition, RSV‐ and FLU‐positive samples collected in PBS showed higher measured IL‐33 levels than those collected in UTM. No significant differences were found for the other viruses included in this study. These findings highlight the importance of considering sample collection and transport conditions when interpreting IL‐33 measurements in NPS, particularly in future studies evaluating IL‐33 as a potential severity‐associated biomarker during RSV or influenza infection.
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Open AccessImpact of Transport Media on IL‐33 Levels in Samples From Patients With Viral Respiratory Infections
Interleukin‐33 (IL‐33) is an IL‐1 family cytokine that activates various immune cells and induces both systemic and localized Th2 responses during infection. An association between IL‐33 and its suppresion of tumorigenicity 2 (ST2) receptor with inflammation during respiratory tract infection has been previously reported. Furthermore, some data suggest that during respiratory infections, IL‐33 may serve as an indicator of disease severity, as high levels of this cytokine have been found in nasopharyngeal swab (NPS) samples of infants with lower respiratory tract disease caused by respiratory syncytial virus (RSV). As viral diagnosis is mostly compartmentalized in NPS, in this report, we aimed at detecting IL‐33 in NPS from patients with respiratory tract infections that were collected in two different transport media (universal transport medium [UTM], and phosphate‐buffered saline [PBS]). IL‐33 levels were evaluated in 230 NPS samples, 121 obtained in PBS, and 109 in UTM. The samples were tested for RSV, metapneumovirus, adenovirus (ADV), influenza, and parainfluenza. In this cohort, higher levels of IL‐33 were detected in virus‐positive samples collected in PBS compared to virus‐negative samples collected in the same transport medium. In addition, RSV‐ and FLU‐positive samples collected in PBS showed higher measured IL‐33 levels than those collected in UTM. No significant differences were found for the other viruses included in this study. These findings highlight the importance of considering sample collection and transport conditions when interpreting IL‐33 measurements in NPS, particularly in future studies evaluating IL‐33 as a potential severity‐associated biomarker during RSV or influenza infection.
- Open Access
- 26 March 2025
- Published by Sociedad Chilena de Pediatria in Andes Pediatrica
- Vol. 96 (2) , 225-234
Factores asociados a Leucomalacia Periventricular en recién nacidos prematuros de muy bajo peso. Estudio multicéntrico en la Red NEOCOSUR
La prevalencia global de la Leucomalacia Periventricular (LPV) se ha mantenido estable, en torno al 4%, en recién nacidos de muy bajo peso al nacer (RNMBPN) en la Red Neonatal NEOCOSUR durante 16 años.Objetivo: Determinar los factores asociados a la presencia de LPV en aquellos RNMBPN sobrevivientes al alta, su incidencia global y por edad gestacional (EG).Pacientes y Método: Estudio observacional, multicéntrico, retrospectivo con datos registrados prospectivamente (período 2012- 2021). Se incluyeron aquellos con peso de nacimiento entre 400 a 1.500 gramos y 23 a 31+6 semanas de EG sobrevivientes al alta. Se realizó un análisis bivariado utilizando la prueba chi-cuadrado de Pearson para contrastar el porcentaje de LPV para variables categóricas y t-Student para contrastar promedios para variables numéricas. Para explorar el efecto independiente de cada variable explicativa se realizó un análisis de regresión logística multivariado.Resultados: En 6825 RNMBPN sobrevivientes, la incidencia global de LPV fue del 8,5%. Los factores asociados a mayor probabilidad de LPV fueron displasia broncopulmonar (DBP) [OR 2,27 IC 95% 1,80-2,87], enterocolitis necrotizante (ECN) [OR 1,78 IC 95% 1,35-2,34], sepsis tardía [OR 1,71 IC 95% 1,34-2,19], hemorragia intracraneana (HIC) severa [OR 4,64 IC 95% 3,51-6,14], Ductus Arterioso (DAP) [OR 1,32 IC 95% 1,06-1,64] y ventilación mecánica (VM) [OR 2,03 IC 95% 1,54-2,67].Conclusión: En RNMBPN sobrevivientes al alta, una mayor probabilidad de LPV se asoció a la presencia de DBP, ECN, sepsis tardía, HIC severa y DAP; y al empleo de VM.
- 26 March 2025
- Published by Sociedad Chilena de Pediatria in Andes Pediatrica
- Vol. 96 (2) , 225-234
Open AccessFactores asociados a Leucomalacia Periventricular en recién nacidos prematuros de muy bajo peso. Estudio multicéntrico en la Red NEOCOSUR
La prevalencia global de la Leucomalacia Periventricular (LPV) se ha mantenido estable, en torno al 4%, en recién nacidos de muy bajo peso al nacer (RNMBPN) en la Red Neonatal NEOCOSUR durante 16 años.Objetivo: Determinar los factores asociados a la presencia de LPV en aquellos RNMBPN sobrevivientes al alta, su incidencia global y por edad gestacional (EG).Pacientes y Método: Estudio observacional, multicéntrico, retrospectivo con datos registrados prospectivamente (período 2012- 2021). Se incluyeron aquellos con peso de nacimiento entre 400 a 1.500 gramos y 23 a 31+6 semanas de EG sobrevivientes al alta. Se realizó un análisis bivariado utilizando la prueba chi-cuadrado de Pearson para contrastar el porcentaje de LPV para variables categóricas y t-Student para contrastar promedios para variables numéricas. Para explorar el efecto independiente de cada variable explicativa se realizó un análisis de regresión logística multivariado.Resultados: En 6825 RNMBPN sobrevivientes, la incidencia global de LPV fue del 8,5%. Los factores asociados a mayor probabilidad de LPV fueron displasia broncopulmonar (DBP) [OR 2,27 IC 95% 1,80-2,87], enterocolitis necrotizante (ECN) [OR 1,78 IC 95% 1,35-2,34], sepsis tardía [OR 1,71 IC 95% 1,34-2,19], hemorragia intracraneana (HIC) severa [OR 4,64 IC 95% 3,51-6,14], Ductus Arterioso (DAP) [OR 1,32 IC 95% 1,06-1,64] y ventilación mecánica (VM) [OR 2,03 IC 95% 1,54-2,67].Conclusión: En RNMBPN sobrevivientes al alta, una mayor probabilidad de LPV se asoció a la presencia de DBP, ECN, sepsis tardía, HIC severa y DAP; y al empleo de VM.
- Open Access
- 12 September 2024
- Published by Sociedad de Cirujanos de Chile in Revista de Cirugía
- Vol. 76 (5)
Indicación de biopsia de linfonodo centinela en CDIS de mama. Estudio cooperativo de factores predictivos de hallazgo de carcinoma invasor postoperatorio.
Introducción:El carcinoma ductal in situ (CDIS) de la mama es un precursor del carcinoma invasor, representando el 20-25% de los diagnósticos de cáncer de mama. La biopsia percutánea preoperatoria no siempre identifica focos de invasión, por lo que informe postoperatorio de carcinoma invasor implica otra cirugía para biopsia de linfonodo centinela (BLC).El objetivo del trabajo es analizar factores clínico-patológico-radiológicos de pacientes con diagnóstico preoperatorio de CDIS que permitan predecir el riesgo de carcinoma invasor postoperatorio y en quienes sería necesario realizar BLC para evitar otra cirugía.Métodos:Se realizó un estudio retrospectivo de 304 pacientes con diagnóstico preoperatorio de CDIS mediante biopsia percutánea en nuestra institución entre 2007 y 2021. La asociación entre las variables y el diagnóstico de carcinoma invasor en el postoperatorio fue analizada con modelos de regresión logística usando análisis univariado y multivariado.Resultados:Se identificaron 304 pacientes con diagnóstico de CDIS puro en la biopsia percutánea. De ellos, 85 (28%) presentaron carcinoma invasor en el análisis postoperatorio.En el análisis multivariado la edad (OR 1,06; IC 95% 1,01-1,11), tamaño de la lesión (OR 1,03; IC 95% 1,01-1,05) y receptores hormonales negativos (OR 5,47; IC 95% 1,61-18,56) resultaron estar asociados a un mayor riesgo de componente invasor postoperatorio.Conclusión:En pacientes con CDIS, las variables edad, tamaño y estado de receptores hormonales son factores pronósticos para encontrar invasión en el estudio postoperatorio. Por lo tanto, deben ser considerados al decidir el tratamiento quirúrgico.
- 12 September 2024
- Published by Sociedad de Cirujanos de Chile in Revista de Cirugía
- Vol. 76 (5)
Open AccessIndicación de biopsia de linfonodo centinela en CDIS de mama. Estudio cooperativo de factores predictivos de hallazgo de carcinoma invasor postoperatorio.
Introducción:El carcinoma ductal in situ (CDIS) de la mama es un precursor del carcinoma invasor, representando el 20-25% de los diagnósticos de cáncer de mama. La biopsia percutánea preoperatoria no siempre identifica focos de invasión, por lo que informe postoperatorio de carcinoma invasor implica otra cirugía para biopsia de linfonodo centinela (BLC).El objetivo del trabajo es analizar factores clínico-patológico-radiológicos de pacientes con diagnóstico preoperatorio de CDIS que permitan predecir el riesgo de carcinoma invasor postoperatorio y en quienes sería necesario realizar BLC para evitar otra cirugía.Métodos:Se realizó un estudio retrospectivo de 304 pacientes con diagnóstico preoperatorio de CDIS mediante biopsia percutánea en nuestra institución entre 2007 y 2021. La asociación entre las variables y el diagnóstico de carcinoma invasor en el postoperatorio fue analizada con modelos de regresión logística usando análisis univariado y multivariado.Resultados:Se identificaron 304 pacientes con diagnóstico de CDIS puro en la biopsia percutánea. De ellos, 85 (28%) presentaron carcinoma invasor en el análisis postoperatorio.En el análisis multivariado la edad (OR 1,06; IC 95% 1,01-1,11), tamaño de la lesión (OR 1,03; IC 95% 1,01-1,05) y receptores hormonales negativos (OR 5,47; IC 95% 1,61-18,56) resultaron estar asociados a un mayor riesgo de componente invasor postoperatorio.Conclusión:En pacientes con CDIS, las variables edad, tamaño y estado de receptores hormonales son factores pronósticos para encontrar invasión en el estudio postoperatorio. Por lo tanto, deben ser considerados al decidir el tratamiento quirúrgico.
- 5 October 2021
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 74 (3) , 424-430
Growth of Very Low Birth Weight Infants Who Received a Liquid Human Milk Fortifier
Objectives: To evaluate growth (weight, length, head circumference, and knee–heel length [KHL]) in very low birth weight (VLBW) infants (500–1500 g) who received human milk with a liquid fortifier (LHMF) with high protein and fatty acid content versus a traditional powder fortifier (PHMF) for 45 days or until discharge.Methods: This was a multicenter, randomized, controlled trial. An intention‐to‐treat analysis was performed to determine adverse events and withdrawal causes. We also performed an efficacy analysis involving the infants who completed at least 2 weeks of study.Results: Of the 158 infants enrolled in the study, 146 completed at least 2 weeks, and 125 completed the entire study. The biodemographic characteristics were similar between groups, with no differences in increments of weight (22.9 vs 22.7 g kg−1 day−1), length (1.03 vs 1.09 cm/week), head circumference (0.91 vs 0.90 cm/week), or KHL (3.6 vs 3.3 mm/week). The KHL increment was greater in infants weighing >1 kg receiving LHMF (3.7 vs 3.2 mm/week, P = 0.027). Although there were no significant differences in serious adverse events, the incidence difference of the composite outcome death/necrotizing enterocolitis between groups warrants attention (1.3% with LHMF and 8.1% with PHMF).Conclusion: There were no differences in the overall growth between VLBW infants receiving either fortifier.
- 5 October 2021
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 74 (3) , 424-430
Growth of Very Low Birth Weight Infants Who Received a Liquid Human Milk Fortifier
Objectives: To evaluate growth (weight, length, head circumference, and knee–heel length [KHL]) in very low birth weight (VLBW) infants (500–1500 g) who received human milk with a liquid fortifier (LHMF) with high protein and fatty acid content versus a traditional powder fortifier (PHMF) for 45 days or until discharge.Methods: This was a multicenter, randomized, controlled trial. An intention‐to‐treat analysis was performed to determine adverse events and withdrawal causes. We also performed an efficacy analysis involving the infants who completed at least 2 weeks of study.Results: Of the 158 infants enrolled in the study, 146 completed at least 2 weeks, and 125 completed the entire study. The biodemographic characteristics were similar between groups, with no differences in increments of weight (22.9 vs 22.7 g kg−1 day−1), length (1.03 vs 1.09 cm/week), head circumference (0.91 vs 0.90 cm/week), or KHL (3.6 vs 3.3 mm/week). The KHL increment was greater in infants weighing >1 kg receiving LHMF (3.7 vs 3.2 mm/week, P = 0.027). Although there were no significant differences in serious adverse events, the incidence difference of the composite outcome death/necrotizing enterocolitis between groups warrants attention (1.3% with LHMF and 8.1% with PHMF).Conclusion: There were no differences in the overall growth between VLBW infants receiving either fortifier.
- 9 May 2016
- Published by Wiley in Muscle & Nerve
- Vol. 55 (1) , 16-22
Maximal isometric muscle strength values obtained By hand‐held dynamometry in children between 6 and 15 years of age
Introduction: In this study we aimed to determine the maximal isometric muscle strength of a healthy, normal‐weight, pediatric population between 6 and 15 years of age using hand‐held dynamometry to establish strength reference values. The secondary objective was determining the relationship between strength and anthropometric parameters. Methods: Four hundred normal‐weight Chilean children, split into 10 age groups, separated by 1‐year intervals, were evaluated. Each age group included between 35 and 55 children. Results: The strength values increased with increasing age and weight, with a correlation of 0.83 for age and 0.82 for weight. The results were similar to those reported in previous studies regarding the relationships among strength, age, and anthropometric parameters, but the reported strength differed. Conclusions: These results provide normal strength parameters for healthy and normal‐weight Chilean children between 6 and 15 years of age and highlight the relevance of ethnicity in defining reference values for muscle strength in a pediatric population. Muscle Nerve 55: 16–22, 2017
- 9 May 2016
- Published by Wiley in Muscle & Nerve
- Vol. 55 (1) , 16-22
Maximal isometric muscle strength values obtained By hand‐held dynamometry in children between 6 and 15 years of age
Introduction: In this study we aimed to determine the maximal isometric muscle strength of a healthy, normal‐weight, pediatric population between 6 and 15 years of age using hand‐held dynamometry to establish strength reference values. The secondary objective was determining the relationship between strength and anthropometric parameters. Methods: Four hundred normal‐weight Chilean children, split into 10 age groups, separated by 1‐year intervals, were evaluated. Each age group included between 35 and 55 children. Results: The strength values increased with increasing age and weight, with a correlation of 0.83 for age and 0.82 for weight. The results were similar to those reported in previous studies regarding the relationships among strength, age, and anthropometric parameters, but the reported strength differed. Conclusions: These results provide normal strength parameters for healthy and normal‐weight Chilean children between 6 and 15 years of age and highlight the relevance of ethnicity in defining reference values for muscle strength in a pediatric population. Muscle Nerve 55: 16–22, 2017